Skip to Content
Interactive Textbook on Clinical Symptom Research Logo


Home button

Trial Design: Pain Sections
Author Bio
Introduction
Placebo Effects
Currently selected section: Single Dose Trials
Repeated Dose Trials
Explanatory Versus Pragmatic
Dose-Response
Parallel Group Versus Crossover
Conclusion
 

 

Chapter 1: Clinical Trials of Pain Treatment: Single Dose Trials: Question 3.8
         What can you conclude about Drug X?

You answered:


Selection A Drug X is effective, as shown by its superiority to morphine, 6 mg.

Treatments were drug X, morphine 12 mg, and morphine 6 mg.  Drug X and morphine 12 mg provided a large amount of relief, similar to each other and statistically greater than did morphine 6 mg.

CORRECT

Drug X is effective, as shown by its superiority to morphine, 6 mg. The difference between Drug X and morphine, 6 mg, as well as the difference between morphine 12 mg and 6 mg, demonstrate assay sensitivity. A placebo would have been necessary if Drug X were a weaker analgesic with efficacy similar to the low dose of morphine. In addition to doses of a test drug, a standard analgesic, and a placebo, most analgesic studies include additional treatment groups or controls that are chosen to further elucidate the major research question. For example, when evaluating a range of doses of test analgesic, one might add additional doses of standard analgesic spanning that analgesic range, both to serve as a comparative yardstick and to verify that the study methods can separate high from moderate analgesic doses.

 

 Back to Question